CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 48 enrolled
Drug / intervention
Ultrasound and MRI +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04175730
NCT04175730N/ACompleted
CompareCT.gov

Prostate Cancer Detection Using a Quantitative Screening MRI Protocol

University of Illinois at Chicago·interventional·Posted Nov 25, 2019·Updated Jun 9, 2022

In Brief

A clinical study evaluating Ultrasound and MRI and Ultrasound for Prostate Cancer. Completed, enrolled 48 participants across 1 site.

Detailed Summary

Whether a quantitative detection specfic magnetic resonance imaging (MRI) protocol improves prostate cancer (PCa) detection in biopsy naïve men is not adequately studied.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedNov 25, 2019
Enrollment StartMay 20, 2019
Primary CompletionDec 14, 2020
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 6.6 years ago

Interventions

Ultrasound and MRIdevice

A single subsequent ultrasound guided prostate biopsy with MRI fusion

Ultrasounddevice

A single subsequent ultrasound guided prostate biopsy